Home / Drug shortages / Rocuronium Bromide Injection

Rocuronium Bromide Injection — FDA Drug Shortage

Current — Meitheal Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Meitheal Pharmaceuticals, Inc. with status Current. The shortage was first posted on 02/15/2023.

Shortage Details

Status
Current
Company
Meitheal Pharmaceuticals, Inc.
Package NDC
71288-718-11
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)
Initial Posting
02/15/2023
Revised Date

FDA data resources